DISAB

Connect with us

National

Early interferon therapy may mitigate COVID-19 severity – News-Medical.Net

A recent review of COVID-19 therapies explores the utility of interferons in the battle against severe COVID-19, and concludes that they deserve further development….

Published

on

The coronavirus disease 2019 (COVID-19) pandemic has now spread for over 10 months, evading capture by effective antivirals. The earliest vaccines are still in phase III of their clinical trials. Remdesivir is among the very few drugs that show even moderate benefit in this illness.
A recent review of COVID-19 therapies published in the journal International Immunopharmacologyin November 2020 explores the utility of interferons in the battle against severe COVID-19, and concludes that they deserve…

Click here to view the original article.

Safety Mate